Powder properties and their influence on dry powder inhaler delivery of an antitubercular drug

被引:0
作者
Sethuraman V.V. [1 ]
Hickey A.J. [2 ]
机构
[1] Department of Biomedical Engineering, University of North Carolina at Chapel Hill, Chapel Hill
[2] School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill
关键词
Aerosol dispersion; Cohesive energy density; Dry powder inhalers; Surface area; Surface energy;
D O I
10.1208/pt030428
中图分类号
学科分类号
摘要
The purpose of this study was to determine if aerosol delivery of drug loaded microparticles to lungs infected with Mycobacterium tuberculosis may be achieved by predicting dispersion of dry powders through knowledge of particle surface properties. Particle sizes of rifampicin-loaded poly (lactide-co-glycolide) microparticles (R-PLGA), rifampicin alone, and lactose and maltodextrin carrier particles (bulk and 75-125-μ sieved fractions) were determined by electron microscopy for the projected area diameter (Dp) and laser diffraction for the volume diameter (Dv). Surface energies (y) of R-PLGA, rifampicin alone, lactose, and maltodextrin were obtained by inverse phase gas chromatography, surface areas (Sa) by N2 adsorption, and cohesive energy densities by calculation. Particle dispersion was evaluated (Andersen nonviable impactor) for 10% blends of R-PLGA and rifampicin alone with bulk and sieved fractions of the carriers. Dp for R-PLGA and rifampicin alone was 3.02 and 2.83 μm, respectively. Dv was 13 ± 1 and 2 ± 1 μm for R-PLGA and rifampicin alone, respectively, indicating that R-PLGA was more aggregated. This was evident in y of 35 ± 1 and 19 ± 6 mJ/m 2 for RPLGA and rifampicin alone. Dp for lactose and maltodextrin (sieved and bulk) was approximately 40 mm. Bulk maltodextrin (Dv = 119 ± 6 mm) was more aggregated than bulk lactose (Dv = 54 ± 2 mm). This was a result of the higher Sa for maltodextrin (0.54 m2/g) than for lactose (0.21 m2/g). The y of bulk lactose and maltodextrin was 40 ± 4 and 60 ± 6 mJ/m 2 and of sieved lactose and maltodextrin was 39 ± 1 and 50 ± 1 mJ/m2. Impaction studies yielded higher fine particle fractions of R-PLGA from sieved lactose, 13% ± 3%, than from sieved maltodextrin, 7% ± 1%, at 90 L/min. An expression, based on these data, is proposed as a predictor of drug dispersion from carrier particles. Delivery of dry powder formulations can be achieved by characterizing particle surfaces and predicting impact on dispersion.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Respiratory Tract: Structure and Attractions for Drug Delivery Using Dry Powder Inhalers
    ElKasabgy, Nermeen A.
    Adel, Islam M.
    Elmeligy, Mohamed F.
    [J]. AAPS PHARMSCITECH, 2020, 21 (07)
  • [22] Respiratory Tract: Structure and Attractions for Drug Delivery Using Dry Powder Inhalers
    Nermeen A. ElKasabgy
    Islam M. Adel
    Mohamed F. Elmeligy
    [J]. AAPS PharmSciTech, 21
  • [23] The influence of physical properties and morphology of crystallised lactose on delivery of salbutamol sulphate from dry powder inhalers
    Kaialy, Waseem
    Martin, Gary P.
    Larhrib, Hassan
    Ticehurst, Martyn D.
    Kolosionek, Ewa
    Nokhodchi, Ali
    [J]. COLLOIDS AND SURFACES B-BIOINTERFACES, 2012, 89 : 29 - 39
  • [24] Dry Powder Inhalers for Delivery of Synthetic Biomolecules
    Omidian, Hossein
    Nokhodchi, Ali
    Babanejad, Niloofar
    [J]. PHARMACEUTICALS, 2025, 18 (02)
  • [25] Agglomerate behaviour of fluticasone propionate within dry powder inhaler formulations
    Le, V. N. P.
    Robins, E.
    Flament, M. P.
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2012, 80 (03) : 596 - 603
  • [26] Liposomal amikacin dry powder inhaler: Effect of fines on in vitro performance
    Shrenik P. Shah
    Ambikanandan Misra
    [J]. AAPS PharmSciTech, 5
  • [27] Liposomal amikacin dry powder inhaler: Effect of fines on in vitro performance
    Shah, SP
    Misra, A
    [J]. AAPS PHARMSCITECH, 2004, 5 (04)
  • [28] Dry Powder Inhalers: Main Characteristics, Classifications and Novel Drug Delivery Systems Review
    Dhahir, Rasha Khalid
    Al-nima, Amina Mudhafar
    Al-bazzaz, Fadia Yassir
    [J]. LATIN AMERICAN JOURNAL OF PHARMACY, 2021, 40 (SI): : 34 - 43
  • [29] Spherical agglomerates of pure drug nanoparticles for improved pulmonary delivery in dry powder inhalers
    Jun Hu
    Yuancai Dong
    Giorgia Pastorin
    Wai Kiong Ng
    Reginald B. H. Tan
    [J]. Journal of Nanoparticle Research, 2013, 15
  • [30] Spherical agglomerates of pure drug nanoparticles for improved pulmonary delivery in dry powder inhalers
    Hu, Jun
    Dong, Yuancai
    Pastorin, Giorgia
    Ng, Wai Kiong
    Tan, Reginald B. H.
    [J]. JOURNAL OF NANOPARTICLE RESEARCH, 2013, 15 (04)